SCHEMBL6087701

SCHEMBL6087701

COC1=C(C(C)C)c2nc(Nc3ccc(N4CCN(C(=O)CN)CC4)cc3)ncc2CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 10/20 0.62
CDK4 P11802 6/20 0.62
CCND1 P24385 3/20 0.62
CCNE1 P24864 3/20 0.62
CDK1 P06493 2/20 0.62
CCNB1 P14635 2/20 0.62
CCNA2 P20248 5/20 0.51
CCNA1 P78396 2/20 0.51
SYK P43405 8/20 0.49
AURKA O14965 3/20 0.49
CCND3 P30281 3/20 0.49
CDK6 Q00534 3/20 0.49
JAK2 O60674 1/20 0.49
JAK1 P23458 1/20 0.49
JAK3 P52333 1/20 0.49
KCNH2 Q12809 1/20 0.47
PIM1 P11309 1/20 0.46
TTK P33981 1/20 0.46
PIM2 Q9P1W9 1/20 0.46
WEE1 P30291 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6087131 0.92 SYK (0.53) CDK2CDK4CCND1CCNE1CDK1
SCHEMBL6086937 0.90 CDK2 (0.57) CDK2CDK4CCND1CCNE1CDK1
SCHEMBL6089233 0.90 CDK2 (0.60) CDK2CDK4CCND1CCNE1CCNA2
SCHEMBL6086415 0.88 CDK2 (0.51) CDK2CDK4CCND1CCNE1CDK1
SCHEMBL6086899 0.88 CDK2 (0.49) CDK2CDK4CCND1CCNE1CDK1
SCHEMBL6088759 0.85 CDK2 (0.66) CDK2CDK4CCND1CCNE1CDK1
SCHEMBL6086207 0.85 CDK4 (0.56) CDK2CDK4CCND1CCNE1CDK1
SCHEMBL7459536 0.83 CDK2 (0.46) CDK2CDK4CCND1CCNE1CDK1
SCHEMBL7470120 0.82 CDK2 (0.47) CDK2CDK4CCND1CCNE1CDK1
SCHEMBL6087139 0.82 CDK4 (0.58) CDK2CDK4CCND1CCNE1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP claimed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO claimed
US-6982260-B1 Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes WARNER-LAMBERT COMPANY (US) 2006-01-03 US disclosed